(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LPAR6 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:1617549 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LPAR6 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO RGD:1617549 6480464 ethylene dichloride results in decreased expression of LPAR6 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1617549 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LPAR6 mRNA CTD PMID:22206623 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:1349646 6480464 lysophosphatidic acid binds to and results in increased activity of LPAR6 protein CTD PMID:18297070 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of LPAR6 mRNA CTD PMID:35192832 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1617549 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1617549 6480464 Tetrachlorodibenzodioxin results in increased expression of LPAR6 mRNA, Tetrachlorodibenzodioxin results in increased expression of P2RY5 mRNA CTD PMID:20159946 , PMID:21889950 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LPAR6 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LPAR6 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LPAR6 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1617549 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LPAR6 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1349646 6480464 Tetrachlorodibenzodioxin results in decreased expression of P2RY5 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1617549 6480464 Tetrachlorodibenzodioxin affects the expression of P2RY5 mRNA CTD PMID:21570461 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1349646 6480464 tetrabromobisphenol A results in increased expression of LPAR6 mRNA CTD PMID:33476716 4,4'-diaminodiphenylmethane increases expression ISO RGD:1617549 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LPAR6 mRNA CTD PMID:18648102 5-fluorouracil decreases expression ISO RGD:1349646 6480464 Fluorouracil results in decreased expression of LPAR6 mRNA CTD PMID:17039268 aflatoxin B1 affects expression ISO RGD:1349646 6480464 Aflatoxin B1 affects the expression of P2RY5 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1349646 6480464 Aflatoxin B1 results in decreased methylation of LPAR6 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1349646 6480464 Tretinoin results in increased expression of LPAR6 mRNA CTD PMID:21934132 , PMID:33167477 arsane affects methylation ISO RGD:1349646 6480464 Arsenic affects the methylation of LPAR6 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1349646 6480464 Arsenic affects the methylation of LPAR6 gene CTD PMID:25304211 azathioprine decreases expression ISO RGD:1349646 6480464 Azathioprine results in decreased expression of LPAR6 mRNA CTD PMID:22623647 belinostat increases expression ISO RGD:1349646 6480464 belinostat results in increased expression of LPAR6 mRNA CTD PMID:26272509 benzo[a]pyrene increases expression ISO RGD:1617549 6480464 Benzo(a)pyrene results in increased expression of LPAR6 mRNA, Benzo(a)pyrene results in increased expression of P2RY5 mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene increases expression ISO RGD:1349646 6480464 Benzo(a)pyrene results in increased expression of LPAR6 mRNA, Benzo(a)pyrene results in increased expression of P2RY5 mRNA CTD PMID:20064835 more ... benzo[a]pyrene decreases expression ISO RGD:1349646 6480464 Benzo(a)pyrene results in decreased expression of P2RY5 mRNA CTD PMID:20106945 , PMID:21632981 benzo[b]fluoranthene increases expression ISO RGD:1617549 6480464 benzo(b)fluoranthene results in increased expression of LPAR6 mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO RGD:1617549 6480464 benzo(k)fluoranthene results in increased expression of LPAR6 mRNA CTD PMID:26377693 beta-naphthoflavone increases expression ISO RGD:1349646 6480464 beta-Naphthoflavone results in increased expression of LPAR6 mRNA CTD PMID:32858204 bisphenol A increases expression ISO RGD:1349646 6480464 bisphenol A results in increased expression of LPAR6 mRNA CTD PMID:33476716 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LPAR6 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A affects expression ISO RGD:1349646 6480464 bisphenol A affects the expression of LPAR6 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1617549 6480464 bisphenol A results in increased expression of LPAR6 mRNA CTD PMID:25594700 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LPAR6 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1617549 6480464 bisphenol A results in decreased expression of LPAR6 mRNA CTD PMID:26063408 bisphenol F increases expression ISO RGD:1349646 6480464 bisphenol F results in increased expression of LPAR6 mRNA CTD PMID:33476716 cadmium atom decreases expression ISO RGD:1349646 6480464 Cadmium results in decreased expression of LPAR6 mRNA CTD PMID:24376830 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of LPAR6 mRNA CTD PMID:33453195 calcitriol increases expression ISO RGD:1349646 6480464 Calcitriol results in increased expression of LPAR6 mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:1349646 6480464 Carbamazepine affects the expression of LPAR6 mRNA CTD PMID:25979313 cisplatin increases expression ISO RGD:1349646 6480464 Cisplatin results in increased expression of LPAR6 mRNA CTD PMID:27392435 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of LPAR6 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1349646 6480464 [NSC 689534 binds to Copper] which results in decreased expression of LPAR6 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of LPAR6 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1349646 6480464 [NSC 689534 binds to Copper] which results in decreased expression of LPAR6 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of LPAR6 mRNA CTD PMID:30556269 crocidolite asbestos decreases expression ISO RGD:1617549 6480464 Asbestos, Crocidolite results in decreased expression of LPAR6 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:1349646 6480464 Cyclosporine results in decreased expression of LPAR6 mRNA, Cyclosporine results in decreased expression of P2RY5 mRNA CTD PMID:20106945 , PMID:25562108 dibutyl phthalate increases expression ISO RGD:1617549 6480464 Dibutyl Phthalate results in increased expression of P2RY5 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1349646 6480464 dicrotophos results in decreased expression of LPAR6 mRNA CTD PMID:28302478 diuron increases expression EXP 6480464 Diuron results in increased expression of LPAR6 mRNA CTD PMID:21551480 diuron decreases expression ISO RGD:1349646 6480464 Diuron results in decreased expression of LPAR6 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO RGD:1349646 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1349646 6480464 Doxorubicin results in decreased expression of LPAR6 mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:1349646 6480464 Endosulfan results in decreased expression of LPAR6 mRNA CTD PMID:28108160 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of LPAR6 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:1617549 6480464 epoxiconazole results in increased expression of LPAR6 mRNA CTD PMID:35436446 folic acid multiple interactions ISO RGD:1617549 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LPAR6 mRNA CTD PMID:22206623 furan increases methylation EXP 6480464 furan results in increased methylation of LPAR6 gene CTD PMID:22079235 gemcitabine decreases expression ISO RGD:1349646 6480464 Gemcitabine results in decreased expression of LPAR6 mRNA CTD PMID:17039268 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of LPAR6 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of LPAR6 mRNA CTD PMID:24136188 lead diacetate decreases expression ISO RGD:1617549 6480464 lead acetate results in decreased expression of LPAR6 mRNA CTD PMID:21829687 lipopolysaccharide decreases expression ISO RGD:1617549 6480464 Lipopolysaccharides results in decreased expression of LPAR6 mRNA CTD PMID:25890327 , PMID:26582142 mercury dibromide increases expression ISO RGD:1349646 6480464 mercuric bromide results in increased expression of LPAR6 mRNA CTD PMID:26272509 methidathion increases expression ISO RGD:1617549 6480464 methidathion results in increased expression of LPAR6 mRNA CTD PMID:34813904 methylisothiazolinone increases expression ISO RGD:1349646 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of LPAR6 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1349646 6480464 methylmercuric chloride results in increased expression of LPAR6 mRNA CTD PMID:28001369 nickel atom decreases expression ISO RGD:1349646 6480464 Nickel results in decreased expression of LPAR6 mRNA CTD PMID:23195993 nickel sulfate decreases expression ISO RGD:1349646 6480464 nickel sulfate results in decreased expression of LPAR6 mRNA CTD PMID:16780908 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LPAR6 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1349646 6480464 Ozone results in increased expression of P2RY5 mRNA CTD PMID:23033980 panobinostat increases expression ISO RGD:1349646 6480464 panobinostat results in increased expression of LPAR6 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1349646 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LPAR6 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1617549 6480464 Acetaminophen affects the expression of LPAR6 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LPAR6 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1349646 6480464 Acetaminophen results in decreased expression of LPAR6 mRNA CTD PMID:29067470 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1617549 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LPAR6 mRNA CTD PMID:36331819 phenformin increases expression EXP 6480464 Phenformin results in increased expression of LPAR6 mRNA CTD PMID:31324951 phenylmercury acetate increases expression ISO RGD:1349646 6480464 Phenylmercuric Acetate results in increased expression of LPAR6 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1349646 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LPAR6 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:1349646 6480464 potassium chromate(VI) results in decreased expression of LPAR6 mRNA CTD PMID:22714537 quercetin decreases expression ISO RGD:1349646 6480464 Quercetin results in decreased expression of P2RY5 mRNA CTD PMID:21632981 quercitrin decreases expression ISO RGD:1349646 6480464 quercitrin results in decreased expression of LPAR6 mRNA CTD PMID:25193878 resorcinol increases expression ISO RGD:1349646 6480464 resorcinol results in increased expression of LPAR6 mRNA CTD PMID:22623647 rotenone increases expression EXP 6480464 Rotenone results in increased expression of LPAR6 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1349646 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1349646 6480464 Silicon Dioxide analog results in decreased expression of LPAR6 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:1617549 6480464 Silicon Dioxide results in decreased expression of LPAR6 mRNA CTD PMID:29203145 sodium arsenite decreases expression ISO RGD:1617549 6480464 sodium arsenite results in decreased expression of LPAR6 mRNA CTD PMID:16014739 testosterone enanthate affects expression ISO RGD:1349646 6480464 testosterone enanthate affects the expression of LPAR6 mRNA CTD PMID:17440010 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LPAR6 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1617549 6480464 Carbon Tetrachloride results in decreased expression of LPAR6 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LPAR6 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of LPAR6 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LPAR6 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of LPAR6 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1349646 6480464 trichostatin A results in increased expression of LPAR6 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1349646 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LPAR6 mRNA CTD PMID:27188386 urethane decreases expression ISO RGD:1349646 6480464 Urethane results in decreased expression of LPAR6 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of LPAR6 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:1349646 6480464 Valproic Acid results in decreased methylation of LPAR6 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1349646 6480464 Valproic Acid results in decreased expression of LPAR6 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid increases expression ISO RGD:1349646 6480464 Valproic Acid results in increased expression of LPAR6 mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO RGD:1349646 6480464 Valproic Acid affects the expression of LPAR6 mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of LPAR6 mRNA CTD PMID:23034163 vorinostat multiple interactions ISO RGD:1349646 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LPAR6 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1349646 6480464 vorinostat results in increased expression of LPAR6 mRNA CTD PMID:26272509 zoledronic acid increases expression ISO RGD:1349646 6480464 zoledronic acid results in increased expression of P2RY5 mRNA CTD PMID:24714768
